Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2
Sam Afkhami, Michael R. D’Agostino, Ali Zhang, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 896-915.e19
Open Access | Times Cited: 264

Showing 1-25 of 264 citing articles:

SARS-CoV-2 viral load and shedding kinetics
Olha Puhach, Benjamin Meyer, Isabella Eckerle
Nature Reviews Microbiology (2022)
Open Access | Times Cited: 296
A multinational Delphi consensus to end the COVID-19 public health threat
Jeffrey V. Lazarus, Diana Romero, Christopher J. Kopka, et al.
Nature (2022) Vol. 611, Iss. 7935, pp. 332-345
Open Access | Times Cited: 172
Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial
Jingxin Li, Shipo Wu, Xiling Guo, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 8, pp. 739-748
Open Access | Times Cited: 117
XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1
Qian Wang, Yicheng Guo, Anthony Bowen, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 3, pp. 315-321.e3
Open Access | Times Cited: 98
Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models
Renee L. Hajnik, Jessica A. Plante, Yuejin Liang, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 662
Open Access | Times Cited: 94
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Antonio Bertoletti, Nina Le Bert, Anthony T. Tan
Immunity (2022) Vol. 55, Iss. 10, pp. 1764-1778
Open Access | Times Cited: 92
Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination
Alexandra Suberi, Molly K. Grun, Tianyang Mao, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 709
Open Access | Times Cited: 70
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report
Jane M. Knisely, Lucas E. Buyon, Rebecca Mandt, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 68
Expansion of cytotoxic tissue-resident CD8+ T cells and CCR6+CD161+ CD4+ T cells in the nasal mucosa following mRNA COVID-19 vaccination
Aloysious Ssemaganda, Huong Mai Nguyen, Faisal Nuhu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 67
Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters
Geraldine Nouailles, Julia M. Adler, Peter Pennitz, et al.
Nature Microbiology (2023) Vol. 8, Iss. 5, pp. 860-874
Open Access | Times Cited: 60
Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization
Tong Ye, Zhouguang Jiao, Xin Li, et al.
Nature (2023) Vol. 624, Iss. 7992, pp. 630-638
Closed Access | Times Cited: 51
XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against emerging SARS-CoV-2 variants
Qian Wang, Yicheng Guo, Anthony Bowen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 43
An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza
Man Xing, Gaowei Hu, Xiang Wang, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Overview of mucosal immunity and respiratory infections in children: a focus on Africa
Richard K. Mwape, Mikhail Barday, Marieke M. van der Zalm, et al.
Current Opinion in Pediatrics (2025)
Closed Access | Times Cited: 1
The role of B cells in COVID-19 infection and vaccination
Shiru Chen, Fei Guan, Fabio Candotti, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 58
Trained immunity is induced in humans after immunization with an adenoviral vector COVID-19 vaccine
Dearbhla M. Murphy, Donal J Cox, Sarah A. Connolly, et al.
Journal of Clinical Investigation (2022) Vol. 133, Iss. 2
Open Access | Times Cited: 57
CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2
Lairun Jin, Zhuopei Li, Xiaoyin Zhang, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 55
Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines
Violette Mouro, Alain Fischer
Mucosal Immunology (2022) Vol. 15, Iss. 4, pp. 584-594
Open Access | Times Cited: 51
Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery
Hezhi Wang, Qin Lu, Xin Zhang, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 970-993
Open Access | Times Cited: 45
Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2
Mariana O. Diniz, Elena Mitsi, Leo Swadling, et al.
Nature Immunology (2022) Vol. 23, Iss. 9, pp. 1324-1329
Open Access | Times Cited: 42
Immune determinants of chronic sequelae after respiratory viral infection
Harish Narasimhan, Yue Wu, Nick P. Goplen, et al.
Science Immunology (2022) Vol. 7, Iss. 73
Open Access | Times Cited: 38
Defending against SARS-CoV-2: The T cell perspective
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection
H. J. Yang, Weiqi Hong, Lei Hong, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 36
The role of trained immunity in COVID-19: Lessons for the next pandemic
Mihai G. Netea, Athanasios Ziogas, Christine Stabell Benn, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 6, pp. 890-901
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top